[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Grail Inc (GRAL)

Grail Inc (GRAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,735,529
  • Shares Outstanding, K 42,917
  • Annual Sales, $ 147,170 K
  • Annual Income, $ -408,350 K
  • EBIT $ -516 M
  • EBITDA $ -353 M
  • 60-Month Beta 3.15
  • Price/Sales 17.34
  • Price/Cash Flow N/A
  • Price/Book 1.09

Options Overview Details

View History
  • Implied Volatility 84.54% (+3.40%)
  • Historical Volatility 70.08%
  • IV Percentile 22%
  • IV Rank 36.76%
  • IV High 114.54% on 10/30/25
  • IV Low 67.09% on 09/04/25
  • Expected Move (DTE 27) 10.84 (17.00%)
  • Put/Call Vol Ratio 0.19
  • Today's Volume 1,097
  • Volume Avg (30-Day) 889
  • Put/Call OI Ratio 0.54
  • Today's Open Interest 26,115
  • Open Int (30-Day) 24,250
  • Expected Range 52.90 to 74.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-2.91
  • Number of Estimates 2
  • High Estimate $-2.84
  • Low Estimate $-2.98
  • Prior Year $-3.18
  • Growth Rate Est. (year over year) +8.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.52 +16.91%
on 06/01/26
79.50 -19.82%
on 05/28/26
+3.03 (+4.99%)
since 05/18/26
3-Month
44.06 +44.67%
on 04/10/26
79.50 -19.82%
on 05/28/26
+15.33 (+31.67%)
since 03/18/26
52-Week
29.95 +112.82%
on 08/20/25
118.84 -46.36%
on 01/22/26
+15.30 (+31.59%)
since 06/18/25

Most Recent Stories

More News
GRAL INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

The law firm of Robbins Geller Rudman & Dowd LLP announces that the Grail class action lawsuit seeks to represent purchasers or acquirers of GRAIL, Inc....

GRAL : 63.74 (+7.22%)
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit

NEW YORK , June 18, 2026 /PRNewswire/ --

GRAL : 63.74 (+7.22%)
Deadline Alert: Grail, Inc. (GRAL) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 4, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who...

GRAL : 63.74 (+7.22%)
GRAL Shareholder Alert: Grail, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt

Grail Projected That the NHS-Galleri Trial Was Powered to Deliver a Statistically Significant Reduction in Late-Stage Cancers; Instead, the Primary Endpoint Was Not Observed, and Investors Lost $51.32...

GRAL : 63.74 (+7.22%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines - GRAL

NEW YORK , June 18, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GRAIL, Inc. ("Grail" or the "Company") (NASDAQ: GRAL).   Such investors are...

GRAL : 63.74 (+7.22%)
Deadline Approaching: Grail, Inc. (GRAL) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Law Offices of Howard G. Smith reminds investors of the upcoming August 4, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Grail, Inc....

GRAL : 63.74 (+7.22%)
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Grail, Inc. (GRAL) Shareholders To Inquire About Securities Fraud Class Action

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or...

GRAL : 63.74 (+7.22%)
GRAL DEADLINE: The Gross Law Firm Reminds GRAIL, Inc. Investors of Upcoming Securities Class Action Deadline

NEW YORK , June 16, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GRAIL, Inc. (NASDAQ: GRAL).

GRAL : 63.74 (+7.22%)
GRAL Court Deadline: GRAIL, Inc. Investors are Notified of the Important August 4 Deadline in the Pending Securities Fraud Class Action Lawsuit

A securities fraud class action lawsuit has been filed on behalf of GRAIL investors after its stock plummeted 50% because GRAIL allegedly misled investors relating to GRAIL's NHS-Galleri cancer...

GRAL : 63.74 (+7.22%)
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit

NEW YORK , June 15, 2026 /PRNewswire/ --

GRAL : 63.74 (+7.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

GRAIL LLC is a biotechnology company. It focuses on developing technologies for early cancer detection. GRAIL LLC is based in Menlo Park, United States.

See More

Key Turning Points

3rd Resistance Point 68.70
2nd Resistance Point 66.43
1st Resistance Point 65.08
Last Price 63.74
1st Support Level 61.47
2nd Support Level 59.20
3rd Support Level 57.86

See More

52-Week High 118.84
Fibonacci 61.8% 84.88
Fibonacci 50% 74.39
Fibonacci 38.2% 63.91
Last Price 63.74
52-Week Low 29.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.